MENU SEARCH
Mercy Sioux City Announces First Use of Resolute Onyx Drug-Eluting Stent for Patients

Mercy Sioux City Announces First Use of Resolute Onyx Drug-Eluting Stent for Patients

Monday, June 26, 2017

Mercy Medical Center - Sioux City today announced its first commercial implant of the newly FDA approved Medtronic Resolute Onyx™ Drug-Eluting Stent (DES). The Resolute Onyx DES builds on the proven clinical performance and superior deliverability of the Resolute Integrity™ DES to further strengthen the gold standard safety and efficacy of DES technology.

Mercy is the only hospital in the area to use the new drug-eluting stent. "This stent is easier for the interventional cardiologist to guide through areas of the vessel that previously would have been difficult to maneuver through," said Mike McCarthy, Director of Mercy's Heart Center.

Connect to a Mercy Health Network site